Holders · period archive

HALO · Halozyme Therapeutics

Q3 2022 13F holders among managers we track latest ownership dossier

Ticker: HALO
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares